RICHMAN ERIC I purchased 9.4% of their position (3.88K shares) of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $6.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/7/2022ACC: 0001104659-22-031172
+3.88K
Net shares
Net buyer
$6.4K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
3.88K acquired
Non-Derivative Transactions3
Common stock
Direct
Shares
+1.58K
Price / share
$1.58
Trade value
$2.50K
% of position
3.8%
3/1/2022
41.08K→42.66K
Common stock
Direct
Shares
+1.30K
Price / share
$1.72
Trade value
$2.24K
% of position
3.0%
3/3/2022
42.66K→43.96K
Common stock
Direct
Shares
+1K
Price / share
$1.62
Trade value
$1.62K
% of position
2.3%
3/4/2022
43.96K→44.96K
Total
Net shares
+3.88K
Net value
$6.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 3/1/2022 | P · Purchase | +1.58K | $1.58 | $2.50K | 3.8% | 41.08K | 42.66K |
| Common stock Direct | 3/3/2022 | P · Purchase | +1.30K | $1.72 | $2.24K | 3.0% | 42.66K | 43.96K |
| Common stock Direct | 3/4/2022 | P · Purchase | +1K | $1.62 | $1.62K | 2.3% | 43.96K | 44.96K |
| Total | +3.88K | $6.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock
IndirectShares owned27.75K
Total
27.75K indirect27.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 27.75K | Indirect |
| Total | 27.75K | 27.75K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported